Progress in the application of molecular biomarkers in gliomas.

作者: Jing Wang , Hong-kai Su , Hua-fu Zhao , Zhong-ping Chen , Shing-shun Tony To

DOI: 10.1016/J.BBRC.2015.07.148

关键词:

摘要: Gliomas are a common adult central nervous system tumor, and glioblastoma (GBM), which has poor prognosis, is the most lethal of all gliomas. The overall survival GBM patients only 12-14 months after diagnosis. With progress in precision personal medication, therapeutic options for various tumors have become gradually dependent on molecular profiles patients. one treatment response relies largely characteristics tumor. Therefore, awareness genetic background each patient will help decision-making regarding best strategy to use. In this review, novel classification gliomas based recent findings their introduced. Representative markers, such as IDH1 mutation, 1p19q co-deletion, MGMT promoter methylation EGFRvIII amplification, described. Furthermore, development non-coding RNAs omics studies briefly discussed. Finally, concept non-invasive detection that could facilitate both diagnosis monitoring presented. There no doubt use profiling by biomarkers indeed improve quality life

参考文章(50)
Ping Zhong, Ying Mao, Aden Ka Yin Chan, Yin Wang, Ho Keung Ng, Yan Xi Li, Wei Zhu, Zhi Feng Shi, Xiao Jie Ding, Yu Yao, Zhen Yu Zhang, Liang Fu Zhou, Surgically treated incidentally discovered low-grade gliomas are mostly IDH mutated and 1p19q co-deleted with favorable prognosis International Journal of Clinical and Experimental Pathology. ,vol. 7, pp. 8627- 8636 ,(2014)
Tarik Tihan, Mitchell S. Berger, Susan M. Chang, Michael D. Prados, Joseph Wiemels, John K. Wiencke, Margaret R. Wrensch, Robert B. Jenkins, Jeanette E. Eckel-Passow, Daniel H. Lachance, Annette M. Molinaro, Kyle M. Walsh, Paul A. Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L. Kosel, Ivan V. Smirnov, Gobinda Sarkar, Alissa A. Caron, Thomas M. Kollmeyer, Corinne E. Praska, Anisha R. Chada, Chandralekha Halder, Helen M. Hansen, Lucie S. McCoy, Paige M. Bracci, Roxanne Marshall, Shichun Zheng, Gerald F. Reis, Alexander R. Pico, Brian P. O’Neill, Jan C. Buckner, Caterina Giannini, Jason T. Huse, Arie Perry, Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors The New England Journal of Medicine. ,vol. 372, pp. 2499- 2508 ,(2015) , 10.1056/NEJMOA1407279
Cancer Genome Atlas Research Network, None, Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. ,vol. 372, pp. 2481- 2498 ,(2015) , 10.1056/NEJMOA1402121
W Wechsler, L Liu, L Liu, G Reifenberger, G Reifenberger, J Reifenberger, C D James, V P Collins, V P Collins, Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. American Journal of Pathology. ,vol. 145, pp. 1175- 1190 ,(1994)
Jie Li, Zachary J. Taich, Amit Goyal, David Gonda, Johnny Akers, Bandita Adhikari, Kunal Patel, Scott Vandenberg, Wei Yan, Zhaoshi Bao, Bob S. Carter, Renzhi Wang, Ying Mao, Tao Jiang, Clark C. Chen, Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas. Oncotarget. ,vol. 5, pp. 7342- 7356 ,(2014) , 10.18632/ONCOTARGET.2350
Heidi Schwarzenbach, Dave S. B. Hoon, Klaus Pantel, Cell-free nucleic acids as biomarkers in cancer patients Nature Reviews Cancer. ,vol. 11, pp. 426- 437 ,(2011) , 10.1038/NRC3066
Toshihiko Wakabayashi, Atsushi Natsume, Hisashi Hatano, Masazumi Fujii, Shinji Shimato, Motokazu Ito, Masasuke Ohno, Satoshi Ito, Masatoshi Ogura, Jun Yoshida, p16 promoter methylation in the serum as a basis for the molecular diagnosis of gliomas. Neurosurgery. ,vol. 64, pp. 455- 462 ,(2009) , 10.1227/01.NEU.0000340683.19920.E3
Sabrina Ronen, Russell Pieper, Joanna Phillips, JL Izquierdo-Garcia, LM Cai, MM Chaumeil, P Eriksson, AE Robinson, RO Pieper, JJ Phillips, SM Ronen, Glioma Cells with the IDH1 Mutation Modulate Metabolic Fractional Flux through Pyruvate Carboxylase PLoS ONE. ,vol. 9, pp. e108289- ,(2014) , 10.1371/JOURNAL.PONE.0108289
Pilar Mur, Ángel Rodríguez de Lope, Francisco Javier Díaz-Crespo, Teresa Hernández-Iglesias, Teresa Ribalta, Concepción Fiaño, Juan Fernando García, Juan Antonio Rey, Manuela Mollejo, Bárbara Meléndez, Impact on prognosis of the regional distribution of MGMT methylation with respect to the CpG island methylator phenotype and age in glioma patients Journal of Neuro-oncology. ,vol. 122, pp. 441- 450 ,(2015) , 10.1007/S11060-015-1738-9
Nada Jabado, Mark W Kieran, Adam M Fontebasso, Simon Papillon-Cavanagh, Jeremy Schwartzentruber, Hamid Nikbakht, Noha Gerges, Pierre-Olivier Fiset, Denise Bechet, Damien Faury, Nicolas De Jay, Lori A Ramkissoon, Aoife Corcoran, David T W Jones, Dominik Sturm, Pascal Johann, Tadanori Tomita, Stewart Goldman, Mahmoud Nagib, Anne Bendel, Liliana Goumnerova, Daniel C Bowers, Jeffrey R Leonard, Joshua B Rubin, Tord Alden, Samuel Browd, J Russell Geyer, Sarah Leary, George Jallo, Kenneth Cohen, Nalin Gupta, Michael D Prados, Anne-Sophie Carret, Benjamin Ellezam, Louis Crevier, Almos Klekner, Laszlo Bognar, Peter Hauser, Miklos Garami, John Myseros, Zhifeng Dong, Peter M Siegel, Hayley Malkin, Azra H Ligon, Steffen Albrecht, Stefan M Pfister, Keith L Ligon, Jacek Majewski, Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma Nature Genetics. ,vol. 46, pp. 462- 466 ,(2014) , 10.1038/NG.2950